~Appoints senior Histopathologist Dr. Jay Mehta, President & Head, Neuberg Oncopath~
September 15, 2022: Neuberg Diagnostics, one of the top 4 Pathology laboratory chains in India, with more than 150 labs and 2000+ collection centers and having a presence in India, South Africa, UAE, and the USA, launched Neuberg Oncopathology Reference Laboratory, a state-of-the-art second opinion Oncopathology laboratory in Mumbai. The lab was inaugurated by Dr. GSK Velu, Chairman and Managing Director, Dr. Sandip Shah, Executive Director, Neuberg Diagnostics Pvt. Ltd., and Dr. Jay Mehta, President & Head, Neuberg Oncopath.
The center will pave way for advanced cancer care diagnosis, with experienced Oncopathologists, and geneticists, and will house all modern technologies & technical infrastructure, to deliver better diagnostic insights to Oncologists across the country and improve the quality of life for cancer patients.
The newly established Neuberg Oncopathology lab, which is located at Vidyavihar, Mumbai, Maharashtra will be headed by Dr. Jay Mehta, President & Head, of Neuberg Oncopath. Dr. Mehta is a senior Surgical Pathologist, specializing in Oncopathology, with over 20 years of clinical experience. He completed his post-graduation from the renowned Tata Memorial Hospital, Mumbai. Besides Oncopathology in general, he has a special interest in Lymphomas, Bone marrow pathology, Gastrointestinal tumors, and Soft tissue sarcomas.
He is one of the few Pathologists in India who practices diagnostic molecular pathology and performs a wide array of molecular tests, including next-generation sequencing for solid and liquid tumors. He was the first pathologist in India to start PDL1 testing. He has a special interest in biomarker testing for solid tumors. He is an active and frequent guest speaker and equally adept at talking about solid and liquid tumors to Pathologists & Medical Oncologists alike.
Speaking on the occasion, Dr. GSK Velu, Chairman, and Managing Director, Neuberg Diagnostics said, “The new Neuberg Oncopathology lab will bring synergy to distributed healthcare infrastructure through technology so that cancer diagnosis can be done at the community level and patient care becomes coordinated and seamless. This center will leverage the capabilities of the Neuberg Centre for Genomic Medicine and spearhead cancer care delivery with a robust belief in the Whole Genome Sequencing (WGS) method to enable understanding of the Indian genomic cancer map. Further, these practices will bring in a generational shift in the way cancer care is delivered in India.”
“Oncopathologists play an essential role by testing tumor samples with various techniques to diagnose cancer and its pathological stage. This would further impact the modality and outcome of treatment and the quality of the patient’s life, post-treatment. And we are delighted to have one of the country’s leading experts, Dr. Jay Mehta, as a part of our team.” added Dr. Velu.
Dr. Jay Mehta, President & Head, Neuberg Oncopath said, “Oncopathology is one of the niche branches of medicine that relates to the diagnosis of cancer through an array of tests carried out on patient’s tumor samples. The newly established laboratory is a second opinion reference laboratory spread over 10,000 square feet and will provide end-to-end reports from Histopathology to Molecular tests which impact precision medicine and personalized cancer treatment. The laboratory is well equipped, with the potential to provide testing of cases from across the county,”
“Neuberg Oncopathology laboratory adds to the list of limited end-to-end Oncopathology services available in the country and will strive to stand out as the preferred option for Medical and Surgical Oncologists from both government and private hospitals across the country,” added Dr. Mehta.